Measles Mitigated

Mitigated measles (lat. morbilli mitigati) is a form of measles that occurs in a milder and milder form compared to the classic course of the disease.

Mitigated measles occurs in individuals who have previously received inadequate immunization against this infection. Most often, this occurs when vaccination is carried out incorrectly (violation of deadlines, storage of the vaccine, etc.) or if the patient has congenital or acquired immunodeficiency.

With mitigated measles, the symptoms are much less pronounced. There is no typical rash or high fever. A slight rash, weakness, runny nose and other catarrhal symptoms may occur. The course of the disease is shorter and easier. Complications rarely develop.

To confirm the diagnosis, a laboratory test is performed - blood ELISA for antibodies to the measles virus. Treatment of mitigated measles is symptomatic. It is carried out to alleviate the patient's condition. In this case, vaccination against measles is indicated repeatedly to form reliable immunity.

Mitigated measles (English m. mitigatived, abbreviated as M. mitigated) is one of the types of acute viral disease that affects children and adults. Previously, it had several names, but then, in most countries, as in the USA, the name “Measles” began to be used.

The disease was first described in the first half of the 17th century under the name chickenpox. Subsequently, a large number of descriptions of this disease appeared. For example, rubella, mumps. In addition, it is a known fact that this disease is considered almost incurable. The only proven method of combating it is a vaccine. It is precisely because of this complexity of prevention and therapy that measles is a most dangerous disease. Although most often those who have had it do not even suspect it.

The causative agent of the disease is a virus that is transmitted airborne